Sponsored Content
• Using up-to-date data ensures budget accuracy for clinical trials. • Budgets require tools for cost savings, defendable processes, and more. • GrantPlan enables budgeting teams to keep costs at fair market value.
IQVIA
Advertisement
Articles by IQVIA
Begin with the End in Mind: The Strategic Benefits of Coordinating Site Budgeting, Contracting, and Payments
ByIQVIA
Sponsored Content
• Managing the financial aspects of sponsor–payer–clinical site relationships • Case study and implications: investigator payments issues
Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval
ByIQVIA
Sponsored Content
This webinar will provide an overview of the Japanese regulations and development in the Japanese market. Live: Thursday, Oct. 31, 2019 at 11am EDT On demand available after airing until Oct. 31, 2020 Register free
How AI/ML and advanced techniques are enhancing clinical development: Lessons learned from use in study design, patient and site ID, safety, and risk-based monitoring
ByIQVIA
Sponsored Content
Using AI/ML and advanced techniques in clinical development is more than just hype – it is greatly enhancing clinical trials today! Learn how pharmaceutical firms are realizing the benefits of better study design, faster recruitment, automated safety approaches and more informed, faster decision-making with risk-based and centralized monitoring. Live: Tuesday, Oct. 1, 2019 at 11am EDT On demand available after airing until Oct. 1, 2020. Register free: Register free
Sponsored Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Moving Beyond Disappointing Pilots: Scaling Adoption of AI-Enablement in Drug Development
2
Clinical Site Readiness for Cell and Gene Therapies: Operational and Supply Chain Challenges as they Scale and as they Expand into the Community Care Setting
3
ACT Brief: Data Provenance and Device Strategy, Cell-Gene Therapy Site Readiness, and Data Harmonization Bottleneck
4
Beyond Compliance: Vivalink's Cecilia Xi, PhD, on Data Provenance and Sustainable Device Strategy in Clinical Trials
5